<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0117">Although it generated considerable enthusiasm, a caveat remains in as so far as bone marrow transplants from patients with a 
 <italic>CCR5</italic> delta32/delta32 mutation are not always successful 
 <xref rid="JVEv5-bib-0028" ref-type="bibr">[28]</xref>. Nevertheless, disabling 
 <italic>CCR5</italic> through gene therapy has been commonly used in an attempt to prevent HIV-1 infection of CD4 T cells.
</p>
